P
Praxis Precision Medicines D
D
PRAX
74.440
USD
-5.12
(-6.44%)
مغلق
حجم التداول
25,629
الربح لكل سهم
-14
العائد الربحي
-
P/E
-8
حجم السوق
1,387,396,120
المقالات
العنوان: Praxis Precision Medicines
القطاع: Healthcare
الصناعة: Biotechnology
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized bya neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.